Introduction {#Sec1}
============

Over the last 2 decades the treatment of stress urinary incontinence (SUI) has shifted to a midurethral sling (MUS) or a mesh-based bladder neck procedure \[[@CR1]\]. Although the surgery was believed to be relatively safe, there has been a steep rise in the number of reported cases of their erosion into the lower urinary tract \[[@CR2]--[@CR10]\]. Mesh erosion was first reported in 2001 but is now recognized as a major long-term complication of MUS surgery with an incidence rate of between 0.6 and 5.4% \[[@CR2], [@CR11]\].

Although the true extent of mesh erosion seems to be under-reported, due to an alarming rise of reported cases in 2018, there was a temporary ban on all MUS procedures in the UK \[[@CR12]\]. These erosions and related complications seem to have happened a few years after the initial surgery, with patients presenting with recurrent urinary tract infections (rUTIs), lower urinary tract symptoms (LUTS), recurrent SUI, haematuria and bladder or pelvic pain \[[@CR13]--[@CR15]\]. While open surgical excision via vaginal or abdominal route could be performed with urethrotomy and reconstruction in some cases \[[@CR16]\], increasingly there are papers that suggest that they can be managed endoscopically.

Endoscopic management of eroded foreign body (FB) can be performed by intravesical resection of the mesh with electrode loop via a resectoscope or laparoscopic scissors \[[@CR17]--[@CR20]\], although it has been increasingly popular to use transurethral endoscopic resection using holmium laser \[[@CR21]\]. These are minimally invasive approaches to a complex clinical problem.

The aim of our systematic review was to ascertain the outcomes of endoscopic management in synthetic sling/mesh erosion following previous incontinence surgery.

Methods {#Sec2}
=======

Evidence acquisition {#Sec3}
--------------------

*Inclusion criteria:* Endoscopic surgical interventions for FB excision including laser procedures for adult patients who previously underwent synthetic sling/mesh procedure for incontinence.Studies in English language reporting on a minimum of three patients. *Exclusion criteria:* Animal studies, case reports and laboratory studiesOpen surgical interventionsMale sling procedures

Search strategy and study selection {#Sec4}
-----------------------------------

A systematic literature search was conducted according to the Cochrane review and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol \[[@CR22], [@CR23]\]. Medical subject headings (MeSH) terms used, but not limited to, were: 'endoscopic', 'laser', 'holmium', 'mesh', 'erosion', 'sling', 'TVT', 'tension-free vaginal tape', 'transobturator tape', 'TOT', 'urethral', 'transurethral', 'resection', 'removal', 'incontinence', 'surgical', 'incision' and 'intervention'. Boolean operators (AND, OR) were used to refine the search. The search strategy was conducted to find relevant articles from CINAHL (1996--December 2018), EMBASE (1996--December 2018), Ovid Medline (1996--December 2018), Cochrane Library (2018), Scopus (1996--December 2018), [Clinicaltrials.gov](http://clinicaltrials.gov), Google Scholar and individual urological journals. The search was confined to all English language articles between January 1996 and December 2018. All original studies were included and two reviewers (S.S and B.K.S.) identified all studies independently; discrepancies were resolved by mutual consensus. Where additional information or clarification was needed, the primary authors of the studies were contacted directly.

The PICO statement for this review is as follows: the population examined was adults who underwent synthetic sling procedures for incontinence. There was no comparative group, and the outcomes were to ascertain the results of endoscopic management following sling erosion.

Data extraction and analysis {#Sec5}
----------------------------

The following variables were extracted from each study: journal and year of publication, study type, time period, presenting symptom, procedure type, time to presentation following initial surgery, location of mesh erosion, complications and their management, success rate and follow-up. We used the standard IUGA/ICS terminology for reporting mesh-associated complications in this manuscript \[[@CR24]\]. Data were collated using Microsoft Excel (Microsoft Corp., Redmond, WA, USA), version 12.2.4.). There was a substantial degree of heterogeneity between studies in both design and reporting, and hence our analysis was limited to narrative synthesis and pooled analysis of mean results.

Results {#Sec6}
=======

Our search produced 931 articles of which 155 abstracts were reviewed and 20 articles (198 patients) met our inclusion criteria and were included in our final review (Fig. [1](#Fig1){ref-type="fig"}) \[[@CR3]--[@CR21], [@CR25]--[@CR27]\]. The removal of eroded sling/mesh was done by laser incision in nine studies, endoscopic approach using transurethral resection (TUR) or cutting it with scissors in seven studies and a mixture of the above two techniques in the remaining four studies (Table [1](#Tab1){ref-type="table"}). In the reported studies, 108 (55%) patients were treated exclusively with laser excision and 90 (45%) were managed by intravesical resection of the mesh with electrode loop via a resectoscope, laparoscopic scissors or forceps.Fig. 1PRISMA flowchart of the included studiesTable 1Summary of demographics and presentationReference/ yearJournalLevel of evidenceNumber of patientsAge in years (median, range)Initial procedure (number of patients)Presenting symptomsTime to presentation after surgery (months) (median, range)Wang et al. 2018Lower Urinary Tract Symptoms4a1254, 40--66TVT (2), TOT (4), mini-invasive (4), Solyx (1), unspecified (1)SUI; UI; dyspareunia; voiding LUTS; mesh-associated stones47, 10--161Chan et al. 2016Journal of Endourology4a1858, 50--60TVT (12); Burch/MMK (5); Bladder neck sling (1)Voiding LUTS; pelvic pain; SUI; rUTIs; mesh-associated stones84, 24--132Lee et al. 2017Female Pelvic Medicine & Reconstructive Surgery4a2255.4, 43--68TVT (2); TOT (16); transvaginal mesh repair for pelvic organ prolapse (4)Voiding LUTS; haematuria; recurrent cystitis; dysuria; mesh-associated stones63.6, 9--113Ogle et al. 2017Int Urogynecol J, Wiley4a1058, 54--66TVT (4), other urethral slings (5), MMK (1)Voiding LUTS; pelvic pain; haematuria; rUTI12, 1--72Campobasso et al. 2014Int Urol Nephrol4a362, 57--65TVTVoiding LUTS; haematuria; dysuriaRange: 60--120Davis et al. 2012The Journal of Urology4a1255, 47--73TVT (10), Burch (1), vesicopexy (1)Voiding LUTS; SUI; rUTIs; haematuria19, 3--84Jo et al. 2011Korean Journal of Urology4a2351, 40--67TVT (8), TOT (11), mini-sling (1), unknown (3)Voiding LUTS31, 2--247Doumouchtsis et al. 2010BJUI International4a664, 49--79TVT (5), TOT (1) Burch (1)Voiding LUTS; rUTIs84, 12--156Sakalis et al. 2011Int Urogynecol J, Wiley4a758, 42--72TVTVoiding LUTS; dysuria; haematuria; rUTI; dyspareunia25, 8--48Frenkl et al. 2008Neurourology and Urodynamics4a1151, 41--84Urethral sling, sacrocolpopexy, colposuspensionVoiding LUTS; dyspareunia; haematuria; SUI35, 3--185Giiri et al. 2005The Journal of Urology4a350, 47--57TVT, Burch, vesicopexyVoiding LUTS; haematuria; rUTIsRange: 1--12Hodroff et al. 2004The Journal of Urology4a3UnknownTVTSUI, haematuriaRange: 1--6Goujon et al. 2018J Gynecol Obstet Hum Reprod4a1358, 43--76TOT (8); TVT (5)Voiding LUTS; UI; rUTI; dysuria; pelvic pain; persistent SUI; haematuria23, 0--127Wijffels et al. 2008Int Urogynecol J, Wiley4a352, 44--59TVTUI; SUI; rUTIsRange: 6--14Oh and Ryu 2009Journal of Endourology4a1448, 41--64TVT (11), TOT (3)Voiding LUTS; UI5, 0--36Velemir et al. 2008Int Urogynecol J, Wiley4a454, 39--66TVT (1), TOT (1), retropubic tape inserted trans-abdominally (2)Voiding LUTS; rUTI34, 2--180Huwyler et al. 2008BJUI International4a568, 63--74TVTDyspareunia; rUTI; UIRange: 1--18Baracat et al. 2005CLINICS4a11UnknownTVTVoiding LUTS; rUTIUnknownFoley et al. 2010BJUI International4a960, 38--75TVT (8), TOT (1)Voiding LUTS, rUTI8, 2--18Castroviejo-Royo et al. 2015Journal of Endourology4a961, 49--70TOT (3), mini-sling (6)Voiding LUTS13,1--79*TVT* tension-free vaginal tape, *TOT* transobturator tape, *UI* urge incontinence, *SUI* stress urinary incontinence, *LUTS* lower urinary tract symptoms, *rUTI* recurrent urinary tract infections

Demographics and clinical presentation {#Sec7}
--------------------------------------

All of the included articles were retrospective case series and reported on 3--23 patients each. The mean age across studies varied from 48 to 68 years, and 149 (75%) had tension-free vaginal tapes (TVT) or transobturator tapes (TOT) as their initial procedure. The journal, year of publication, level of evidence and time to presentation after their original surgery are reported in Table [1](#Tab1){ref-type="table"}.

Voiding lower urinary symptoms (LUTS) was the most commonly reported symptom (17 studies). Other symptoms included recurrent UTIs (11 studies), haematuria (9 studies), SUI (6 studies), urge incontinence (UI) (5 studies), dyspareunia (7 studies), dysuria (4 studies) and pelvic pain (3 studies). Mesh-associated stones were a common finding across the literature in patients with urinary mesh erosion. The median time to presentation after their initial surgery was 34.5 months (range: 1--247 months).

Site of mesh erosion {#Sec8}
--------------------

The site of mesh erosion was the bladder in 134 patients (68%), of which 12 (6%) were in the bladder neck. Urethral mesh erosion was seen in 63 patients (32%) across all studies.

Outcomes with laser incision {#Sec9}
----------------------------

One hundred eight (55%) patients were treated exclusively with laser incision (Table [2](#Tab2){ref-type="table"}). The initial and final success rate with this technique was 67% (72 patients) and 92% (99 patients) respectively. Of these patients, 27 needed further laser procedures, with 18 (17%) needing one additional procedure, 6 (5.6%) needing two additional procedures and 3 (2.8%) needing multiple (\> 2) procedures. Of the remaining nine patients, eight (7%) needed vaginal surgery to remove a mesh remnant and one needed open cystotomy to remove the eroded mesh.Table 2Summary of procedures, outcomes and complicationsReference/ yearNumber of patientsLocation of mesh erosionType of endoscopic procedureFollow-up duration (months)Complications (number of patients)Management of complicationsRecurrence of mesh erosion (number of patients)Repeat operations (number of patients)Initial success rateFinal success rateWang et al. 201812UHolmium laser14--70None reportedNone6Multiple repeat procedures (1); vaginal surgery (5)50%58%Chan et al. 201618B (6)BN (4)U (8)Holmium laser12--24Worsening SUI (7), new SUI (1), post-op UTI (2)None41 Repeat procedure(3); 2 repeat procedures (1)78%100%Lee et al. 201722B (16)U (6)Holmium laser23.2SUI (5)None61 repeat procedure (5); 2 repeat procedures (1)73%100%Ogle et al. 201710B (6) U (4)Holmium laser27SUI (3)None31 Needed further procedure for SUI60%100%Campobasso et al. 20143BHolmium laser ± endoscopic forceps15UnknownNone11 Recurrent mesh treated with repeat procedure67%100%Davis et al. 201212B (10)U (2)Holmium laser (10), thulium laser (2)6--134SUI (2)None51 Repeat procedure (4); open cystostomy (1)58%92%Jo et al. 201123B (20)U (3)TUR with electrode loop (16); Holmium laser(7)2Vesicovaginal fistula following TUR with electrode (2); SUI (1)Fistula repair6TURE: 1 Further procedure for mesh removal (1) TURH: transvaginal removal (3); repeat procedure (2)74%87%Doumouchtsis et al. 20106B (2)U(4)Holmium laser12--36SUI (1), voiding difficulty(1)None31 Needed partial cystectomy, repeat procedure (2)50%83%Sakalis et al. 20117BHolmium laser12None reportedNone0Nil100%100%Frenkl et al. 200811B (9)BN (7)U (6)Holmium laser (4), scissors (4), endoscopic TUR (2)UnknownUnknownNone2Repeat procedure (2)82%100%Giiri et al. 20053BHolmium laser3--12SUI (1)None0Nil100%100%Hodroff et al. 20043B (2)BN (1)Holmium laser1SUI (2)None0Nil100%100%Goujon et al. 201813B (10)U (3)Cystoscopy + suprapubic percutaneous access + laparoscopic scissors/holmium laser6Intra-peritoneal bladder perforation (1); retroperitoneal bladder perforation (1); vesicovaginal fistula (1)Conversion to laparoscopy for diagnosed perforation (2); fistula repair (1)62 Repeat procedures (4); 5 procedures (1); 6 procedures (1)54%100%Wijffels et al. 20083UEndoscopic scissorsUnknownSUI (2)None1Repeat procedure (1)67%100%Oh and Ryu 200914BEndoscopic TUR3--12 Cystoscopy; 5--40 (clinical)Vesicovaginal fistula (1); full-thickness perforation and haematoma (1); mild SUI (1); UUI (1)Fistula repair; Surgical drainage of haematoma1Repeat procedure (1)93%100%Velemir et al. 20084UEndoscopic TUR6--24SUI (3)None2Repeat procedures (2)50%100%Huwyler et al. 20085BTUR3--23SUI (1)None0Nil100%100%Baracat et al. 200511B (6)U (5)Bladder erosion-lap-assisted endoscopic excision; urethral erosion-endoscopic excision6SUI (3)None1Repeat procedure (1)91%100%Foley et al. 20109B (6)U and B (3)Endoscopic TUR or direct excision with nasal speculumUnknownSUI (9)None4Repeat procedure (2); open surgery (2)56%78%Castroviejo-Royo et al. 20159BTUR with electrode loop38None reportedNone0Nil100%100%*B* bladder, *BN* bladder neck, *U* urethra, *SUI* stress urinary incontinence, *UUI* urge urinary incontinence, *TUR* transurethral resection

Post-operative complications were seen in 26 (24%) patients. These included SUI in 23 (21%), urinary tract infection in 2 (1.9%) and voiding difficulty in 1 patient. There were no other reported major complications such as fistula formation or intra-operative perforation.

Outcomes with endoscopic procedure using resectoscope/electrode loop or laparoscopic scissors/forceps {#Sec10}
-----------------------------------------------------------------------------------------------------

Ninety (45%) patients were managed using TUR with an electrode loop or laparoscopic scissors/forceps. The initial and final success rates with this technique were 80% (72 patients) and 98% (88 patients) respectively. Of these patients, 16 needed further endoscopic procedures, with 10 (11%) needing one additional procedure, 4 (4%) needing two additional procedures and 2 (2%) needing multiple (\> 2) procedures. The remaining two patients needed open surgery to remove the eroded mesh.

Post-operative complications were seen in 25 (28%) patients. These included SUI in 19 (21%), vesicovaginal fistula in 3 (3%), intra-peritoneal bladder perforation needing a further procedure in 2 (2%) and retroperitoneal bladder perforation in 1 patient.

Discussion {#Sec11}
==========

Meaning of the study {#Sec12}
--------------------

While there is increasing concern about the growing numbers of mesh or sling erosions, all types of surgical intervention carry a risk of morbidity. Bearing in mind the limitations of our review, which is based on retrospective case series, endourological techniques show excellent success rates of \> 90% with endoscopic techniques using laser excision or endoscopic resection, although 20--25% patients may need more than one endoscopic procedure to achieve this. Considering the lack of an open comparator group and reporting bias, the real success rate could be much lower. While the complication rates seem to be 24--28%, one would argue that the majority of these were SUI, which is expected as an outcome of mesh removal irrespective of whether it is done endoscopically or as an open approach, and this may not really count as a complication but probably as an expected outcome of the mesh removal procedure.

Outcomes with practical considerations related to mesh erosion {#Sec13}
--------------------------------------------------------------

Polypropylene meshes play a huge role in the minimally invasive repair of pelvic organ prolapse (POP) and SUI \[[@CR28]\]. However, this also presents complications of mesh misplacement, migration or erosion \[[@CR4]\]. FB erosion following urinary incontinence surgery can be a late complication and may be associated with the material used, operating surgeon's expertise and technical difficulties at the time of initial surgery \[[@CR4], [@CR13]\]. Unrecognized bladder perforation during trocar insertion can also cause mesh erosion and may present as a late complication \[[@CR3]\].

Often presenting with voiding LUTS, recurrent UTIs and haematuria, other symptoms identified in our review included SUI, urge incontinence (UI), dysuria and dyspareunia. The median time of presentation after surgery was 34 months, and a low index of suspicion is necessary in these patients with a previous history of incontinence-related procedures. This delay in presentation can be due to vague non-specific symptoms and a lack of standardized follow-up \[[@CR29]\]. A high index of suspicion is often needed, and a detailed evaluation is necessary often with a cystoscopy to examine the LUT, which can help to confirm the diagnosis. Mesh-associated stones are not uncommon and the presence of stones should raise a strong suspicion of mesh erosion.

Our review of the literature, which is the largest to date, shows that endoscopic management is a feasible and effective option in managing FB erosion. Holmium laser was associated with an overall success rate of 92% and endoscopic management with resectoscope/laparoscopic scissors had a success rate of 98%. The most common complication was SUI in both groups; however it was largely unclear whether this was de novo or a pre-existing complaint. SUI following removal of mesh surgery can be due to a failed incontinence procedure but equally mesh erosion can damage the urethra and sphincter resulting in scarring. The management of this can be complicated and may need reconstructive surgery with urethroplasty to help improve functional outcome \[[@CR4]\]. Endoscopic management with resectoscope and electrode loop and the use of laparoscopic scissors was associated with vesicovaginal fistula in three patients and bladder perforation in two patients. It is worth noting that the laser approach allowed for decreased post-operative morbidity and complications, decreased inpatient hospital stay and good functional outcomes \[[@CR7]\]. However, the outcomes of the two approaches may not be directly comparable because of different populations, variation in techniques and different surgical expertise.

Implications for clinical practice {#Sec14}
----------------------------------

The duration of follow-up varied across all studies and ranged from 1 to 134 months. We suspect it is important for all patients to have long-term outpatient-based follow-up and perhaps have a vaginal speculum examination along with a flexible cystoscopy 6--12 months post-operatively to pick up any early signs of mesh erosion \[[@CR30]\]. This could be repeated if there are any obvious symptoms or a clinical suspicion of erosion. Presence of bladder or urethral stones especially if adherent to the musoca suggests an erosion. The patients should also be counselled to return for a review if they develop persistent or worsening urinary symptoms. Patients at high risk of potential mesh-related complications seem to be those who have a combined mesh for POP repair and SUI mesh sling \[[@CR30]\]. In a study of 41,604 women in the US who underwent transvaginal mesh repair for POP with or without concurrent sling for SUI, transvaginal POP repair without mesh but with concurrent sling or a sling for SUI only and a follow-up period of 1-year, the risk of erosion was 2.7% and the risk of repeated surgery with concomitant erosion was 2.1% in the POP repair with mesh plus sling group \[[@CR30]\]. The SUI sling group on its own had an erosion rate of 1.5% and a risk of repeated surgery with concomitant erosion of 1.6%. Similarly, concomitant hysterectomy and hypertension were also associated with mesh erosions \[[@CR31]\]. In high-risk patients the index of FB erosion and early counselling and appropriate management should be made available.

Strengths, limitations and areas of future research {#Sec15}
---------------------------------------------------

In this review we adhere to the methodological approach of the Cochrane guidelines and PRISMA checklist. It summarizes the role of endoscopic management of mesh erosions including the use of both laser and transurethral resection and gives an overview of the success rate and complications with this technique, although all papers included in our review were retrospective case series and hence prone to bias. Furthermore, there was a lot of heterogeneity in the reported studies making it challenging to do a formal meta-analysis. There are some limitations to our systematic review. Individual studies did not have a standardized management or follow-up, and this was left to the individual surgeon and centre based on their expertise and patient presentation. Given that data collection and reporting were not standardized either, it was difficult to compare or combine outcomes.

A recent study looked at the reporting outcome measures in trials on synthetic mesh procedures for POP and concluded that urgent action is needed to improve the quality of research in this field \[[@CR32]\]. Of the 71 randomized trials, 24 different types of mesh were identified. These trials reported on 110 different outcomes and 60 outcome measures. Clinically important measures such as erosion, pain and dyspareunia were reported in 40, 29 and 25 trials respectively. They recommend developing and implementing a minimum standardized data set, which forms the core outcomes of this procedure. Another systematic review on the type of synthetic material used found that polyester sling material caused the highest rates of vaginal erosion \[[@CR33]\]. The US Food and Drug Administration (FDA) has ordered all manufacturers of surgical mesh intended for transvaginal repair of prolapse (cystocoele) to stop selling and distributing the product \[[@CR34]\]. Given the scale of mesh erosions and the public outcry associated with it, perhaps a national registry of all sling or mesh procedures should be the way ahead, where every case is registered and the core outcome measures including the type of material used, surgical technique, complications and follow-up are mandatory. This should be protocol based and have outcome measures which are standardized and hence comparable.

Conclusions {#Sec16}
===========

Endoscopic management of FB erosion is an effective minimally invasive technique with good outcomes and minimal morbidity, which uro-gynaecologists or endourologists might be able to offer as a treatment option. Management with the use of holmium laser is gaining momentum and could be attempted before open surgical removal. There is a need for comparative data between open surgical excision and endoscopic excision to help better describe the patient's most likely to benefit from the endoscopic technique.
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